Respiratory tract infections (RTIs) are the most common, and potentially most severe, of infections treated by healthcare practitioners.
Lower RTIs along with influenza, are the most common cause of death by infection in the United States. Identifying the causative pathogen(s) rapidly and accurately is key in deciding on a proper treatment protocol. Pure Diagnostic is now offering a new solution to pathogen detection in RTIs, Real-Time Polymerase Chain Reaction for Respiratory Tract Microbiota (qPCR).
Using the latest molecular biology techniques, Pure Diagnostic is able to use the genetic material of the pathogen (DNA, RNA) to accurately identify the species of the pathogen and to detect resistance genes expressed by the pathogen to certain pharmacotherapies.